Stock NEOGENOMICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News NeoGenomics, Inc. OTC Bulletin Board

Equities

US64049M2098

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for NeoGenomics, Inc.
05-28 NeoGenomics, Inc. to Introduce Comprehensive Lung Solution & Feature Hematopathology Services At ASCO CI
05-02 North American Morning Briefing : Stock Futures -3- DJ

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Fort Myers’ Mayor to Proclaim June as NeoGenomics’ Commitment to Cancer Month
BU
NeoGenomics to Introduce Comprehensive Lung Solution and Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management
AQ
NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management
BU
NeoGenomics, Inc. to Introduce Comprehensive Lung Solution & Feature Hematopathology Services At ASCO
CI
North American Morning Briefing : Stock Futures -3-
DJ
Needham Lowers Price Target on NeoGenomics to $19 From $24 Due to Peer Multiple Compression, Maintains Buy Rating
MT
Neogenomics Seeks M&A
CI
Transcript : NeoGenomics, Inc., Q1 2024 Earnings Call, Apr 30, 2024
NeoGenomics: Q1 Earnings Snapshot
AQ
Earnings Flash (NEO) NEOGENOMICS Reports Q1 Revenue $156.2M, vs. Street Est of $149.7M
MT
NeoGenomics Reports First Quarter 2024 Results
BU
NeoGenomics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
NeoGenomics, Inc. Reaffirms Consolidated Earnings Guidance for the Full Year 2024
CI
NeoGenomics Announces Senior Leadership Promotions
BU
NeoGenomics, Inc. Announces Senior Leadership Promotions
CI
NeoGenomics, Inc. Announces Eliminates of Position of Vishal Sikri, President, Advanced Diagnostics
CI
NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024
BU
NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting
BU
NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report
BU
NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NEO Stock
  4. Stock
  5. News NeoGenomics, Inc.